Case Prep: Vestibular Schwannoma (Acoustic Neuroma) Resection

Case / Approach Snapshot

• Anatomy at risk: tumor compartment, arterial supply, venous drainage/sinuses, cranial nerves, white-matter tracts, pituitary/CSF pathways when relevant, and functional cortex.
• Operative steps: review imaging and goals, choose exposure, obtain brain relaxation, devascularize when possible, debulk internally, dissect capsule from critical structures, verify extent/safety, and reconstruct watertight closure; use the detailed operative sequence and approach notes below as the step-by-step source.
• Rescue plans: venous or arterial injury, swelling, seizure, cranial nerve or endocrine change, CSF leak, residual tumor left for safety, staged surgery, radiation, or adjuvant therapy.
• Figures: review Figures, Imaging & Video and the Curated Image Set; embedded local figures should remain open-access, public-domain, or otherwise reusable with attribution.
• Papers: review High-Yield Literature for seminal sources, modern reviews, and outcome data specific to this page.

One-Liner

[Age]yo [M/F] with a [size] cm [left/right] vestibular schwannoma (Koos grade [I-IV]) presenting with [hearing loss/tinnitus/facial numbness/imbalance] planned for [retrosigmoid/translabyrinthine/middle fossa] craniotomy for [gross total/near total/subtotal] resection.

Figures, Imaging & Video

🎥 Operative video — Extended Retrosigmoid Craniotomy for Vestibular Schwannoma · Barrow Neurological Institute

More operative video: YouTube ▸ · Neurosurgical Atlas ▸

🧭 Operative approach: Retrosigmoid craniotomy — detailed corridor setup, step-by-step technique & figures

Neurosurgical Atlas · Radiopaedia · PubMed Central — operative figures © linked; see media-sources.md

MRI/CT fusion: tumor (yellow), sigmoid sinus (blue), labyrinth (green); lateral vs medial type relative to the lateral safe line. Source: Jia et al., Front Surg 2022;9:889402, Fig 1. CC BY 4.0.

Microscopic view of the intrameatal tumor (blue) / IAC fundus (green) interface, with postop imaging confirming complete resection and intact labyrinth. Source: Jia et al., Front Surg 2022;9:889402, Fig 3. CC BY 4.0.

High-Yield Literature

• EANO guideline on the diagnosis and treatment of vestibular schwannoma — Goldbrunner R. Neuro-oncology 2020. PubMed
• Vestibular schwannoma microsurgical technique — Rutherford SA. Handbook of clinical neurology 2025. PubMed
• Hearing Rehabilitation in Vestibular Schwannoma — Mankekar G. Audiology research 2023. PubMed
• Genomics of vestibular schwannoma — Smith MJ. Handbook of clinical neurology 2025. PubMed
• The inflammatory microenvironment in vestibular schwannoma — Hannan CJ. Neuro-oncology advances 2020. PubMed
• Retrosigmoid approach to vestibular schwannoma — Shapey J. Handbook of clinical neurology 2025. PubMed
• Hearing Aid in Vestibular-Schwannoma-Related Hearing Loss: A Review — Di Pasquale Fiasca VM. Audiology research 2023. PubMed
• History of vestibular schwannoma management — Ramsden R. Handbook of clinical neurology 2025. PubMed
• Management of Complications in Vestibular Schwannoma Surgery — Kutz JW Jr. Otolaryngologic clinics of North America 2023. PubMed
• Vestibular schwannoma unveiled by pregnancy: A case report and literature review — Kadir V. European journal of obstetrics, gynecology, and reproductive biology 2024. PubMed

Curated Image Set

Open-access figures are embedded from PubMed Central articles and kept unique to this guide.

Graphical Abstract. Source: Alternatively activated macrophages are associated with faster growth rate in vestibular schwannoma — Brain Communications 2024; CC BY.

Figure 3. Growing VS have more cells residing in proliferative, immune-enriched neighbourhoods. (A) Schematic detailing how the cells within a three-step connection from the target cell define a… Source: Alternatively activated macrophages are associated with faster growth rate in vestibular schwannoma — Brain Communications 2024; CC BY.

Figure 4. Classically activated TAMs associate with alternatively activated TAMs in static but not growing VS. (A) Schematic detailing how significant positive and negative cell–cell spatial… Source: Alternatively activated macrophages are associated with faster growth rate in vestibular schwannoma — Brain Communications 2024; CC BY.

Figure 4. Source: Sudden Sensorineural Hearing Loss and Facial Palsy in Patients with Vestibular Schwannoma Based on the Population Data of Korea — J Int Adv Otol. 2023 Nov 1;19(6):468–71. doi: 10.5152/iao.2023.231121; CC BY-NC.

Figure 5. Source: Immunological Analysis of Vestibular Schwannoma Patients — J Int Adv Otol. 2023 Jan 1;19(1):1–4. doi: 10.5152/iao.2023.22581; CC BY-NC.

Figure 1.. Level of growth factors in the tumor growth group vs. the no tumor growth group. Source: Immunological Analysis of Vestibular Schwannoma Patients — The Journal of International Advanced Otology 2023; CC BY-NC.

Figure 2.. Concentration of carcinoembryonic antigen in patients with different stages of vestibular schwannoma in comparison to the control group. Source: Immunological Analysis of Vestibular Schwannoma Patients — The Journal of International Advanced Otology 2023; CC BY-NC.

Figure 1. Juvenile nasopharyngeal angiofibroma and cleft lip and cleft palate.A 38-year-old man has atrophy of the right temporal area (arrows) resulting from the surgical treatment of his… Source: A Man with Juvenile Nasopharyngeal Angiofibroma, Vestibular Schwannoma, Cleft Lip and Cleft Palate, and Various Nevi: Case Report and Review — Cureus 2018; CC BY.

Figure 2. Compound dysplastic nevus with mild atypia on the right mid-back.Distant (A) and closer (B) views of an oval dark brown patch (arrow) on the right mid-back. Microscopic examination of… Source: A Man with Juvenile Nasopharyngeal Angiofibroma, Vestibular Schwannoma, Cleft Lip and Cleft Palate, and Various Nevi: Case Report and Review — Cureus 2018; CC BY.

Figure 3. Combined (blue and intradermal) nevus of the right mid-chest.Distant (A) and closer (B) views of a small black macule (arrow) on the right mid-chest. Microscopic examination of the shave… Source: A Man with Juvenile Nasopharyngeal Angiofibroma, Vestibular Schwannoma, Cleft Lip and Cleft Palate, and Various Nevi: Case Report and Review — Cureus 2018; CC BY.

History of Present Illness

• Chief complaint: Unilateral sensorineural hearing loss / tinnitus / imbalance / facial numbness
• Duration and progression:
• Hearing: Unilateral progressive sensorineural hearing loss; sudden hearing loss in some
• Tinnitus: Unilateral
• Vestibular: Imbalance (rarely vertigo — slow-growing tumor allows compensation)
• Facial sensation: Numbness (CN V compression — large tumors)
• Facial weakness: Rare at presentation unless very large
• Headache: Suggests hydrocephalus (large tumors with brainstem compression)
• NF2: Bilateral vestibular schwannomas = NF2 (different management)

Past Medical History

• NF2 (neurofibromatosis type 2) — bilateral VS; hearing preservation paramount
• Prior hearing loss (baseline hearing status critical for approach selection)
• Prior radiation (gamma knife, proton beam)
• Prior surgery
• Allergies:
• Medications:

Imaging Review

MRI Brain/IAC (Thin-cut T1+Gad, T2, CISS/FIESTA)

• Size: __ x __ x ___ cm (largest CPA component)
• Koos classification:
  • Grade I: Intracanalicular only
  • Grade II: Extends into CPA, < 2 cm
  • Grade III: Fills CPA but no brainstem contact, 2-3 cm
  • Grade IV: Brainstem compression, > 3 cm
• IAC involvement: Fundus extension, canal widening
• Brainstem compression: Degree of displacement, 4th ventricle compression
• Hydrocephalus: Present/absent
• Cerebellopontine angle: Tumor filling, cistern obliteration
• Cranial nerves:
  • CN VII (facial nerve): Often displaced anteroinferiorly by tumor
  • CN V: Contact or compression (large tumors)
  • CN VIII: Origin nerve (superior vs inferior vestibular)
• Cystic component: Cystic tumors can be more adherent to facial nerve
• Enhancement: Homogeneous (typical) vs heterogeneous

CT Temporal Bone

• IAC widening
• Posterior fossa bony anatomy
• Vestibular aqueduct
• Cochlear apparatus (hearing preservation planning)

Audiometry

• Pure tone audiogram: SRT, speech discrimination score (SDS)
• Serviceable hearing: AAO-HNS Class A or B (SDS >= 50%, PTA <= 50 dB)
• Non-serviceable hearing: Class C or D
• ABR (auditory brainstem response): Wave V latency
• Word recognition score (WRS): Critical for approach selection

Labs

• CBC, BMP, Coags
• Type and crossmatch
• Genetic testing for NF2 if bilateral or young

Neurological Examination

Cranial Nerves (Detailed)

• CN V: Facial sensation (V1, V2, V3), corneal reflex, masseter
• CN VII: House-Brackmann grade at baseline (I = normal, VI = total paralysis)
• CN VIII:
  • Hearing: Weber (lateralizes to GOOD ear), Rinne (positive both sides if sensorineural)
  • Vestibular: Romberg, head thrust test, nystagmus
• CN IX-XII: Lower cranial nerves (large tumors)

Cerebellar

• Gait, tandem walking, coordination

Surgical Planning

Case Logistics, OR Needs & Orders

• OR setup: Mayfield, navigation, microscope/endoscope, cranial nerve monitoring/BAER when relevant, EVD/CSF diversion plan, watertight closure and fat/fascia graft materials, and blood available for vascular tumors.
• Special needs: arterial line, Foley, dexamethasone for edema, antiemetic plan, lower-CN airway/swallow contingency, EVD/ETV plan for hydrocephalus, and audiology/facial-nerve baseline when relevant.
• Immediate postop orders: ICU neuro checks, CN/eye movement/facial/swallow/voice exams, HOB 30, CT for hemorrhage/hydrocephalus, MRI for EOR, CSF-leak/pseudomeningocele watch, dex taper, and early swallow/ENT consult when lower CN risk exists.

Approach Selection — CRITICAL DECISION

• Middle fossa: Koos I, serviceable hearing, tumor < 1.5 cm
• Retrosigmoid: Koos II-III, serviceable hearing, tumor with CPA component
• Translabyrinthine: Koos III-IV, non-serviceable hearing, large tumors (best facial nerve outcome for large tumors)

Position

Retrosigmoid:

• Lateral/park bench (ipsilateral side up) or supine with head turned
• Head flexed, vertex tilted down, mastoid highest point
• Mayfield skull clamp

Translabyrinthine:

• Supine, head turned contralateral, ipsilateral ear up
• Mayfield clamp
• Shoulder roll

Middle Fossa:

• Supine, head turned 90 degrees, ipsilateral ear up
• Mayfield clamp

Key Surgical Steps (Retrosigmoid Approach)

1. Retrosigmoid craniotomy — expose sigmoid and transverse sinus junction
2. Dural opening — based on sinuses
3. CSF drainage — cerebellomedullary cistern for relaxation
4. Cerebellar retraction — minimal, gravity-assisted
5. Identify tumor in CPA — debulk the center (CUSA) to reduce tumor volume
6. Identify CN VII — CRITICAL
   • Typically displaced ANTEROINFERIORLY
   • Use facial nerve EMG stimulator to locate nerve on tumor capsule
   • CN VII course: brainstem → across CPA → tumor capsule (often splayed) → IAC → fundus
7. Progressive tumor removal:
   • Internal debulking first
   • Then capsule dissection from medial to lateral
   • Identify and preserve the arachnoid plane between tumor and brainstem/cerebellum
   • Identify CN VII on tumor capsule — dissect tumor OFF the nerve, NOT nerve off tumor
8. Drill posterior wall of IAC — to access intracanalicular component
   • Identify transverse crest (Bill’s bar) — CN VII is ANTERIOR to Bill’s bar
   • Leave a bone shell over the posterior semicircular canal (if hearing preservation)
9. Remove intracanalicular tumor — work lateral to medial
10. Final facial nerve confirmation — stimulate along entire course
11. Hearing preservation: If attempting, monitor BAER continuously; preserve cochlear nerve
12. Hemostasis: Pack IAC with fat graft + bone wax (prevent CSF leak)
13. Dural closure: Watertight with graft if needed

Critical Anatomy & Structures at Risk

1. Facial nerve (CN VII) — the priority structure; displaced by tumor but usually anatomically continuous. Stimulate frequently to map location
2. Cochlear nerve (CN VIII cochlear division) — if hearing preservation attempted; runs with CN VII
3. AICA — may be displaced or encased; gives off labyrinthine artery
4. Labyrinthine artery — end artery to inner ear; injury → total hearing loss
5. Trigeminal nerve (CN V) — compressed superiorly by large tumors
6. Lower cranial nerves (IX, X, XI) — at risk with large tumors extending to jugular foramen
7. Brainstem — medially; avoid any traction or thermal injury
8. Petrosal vein — may need sacrifice for exposure; risk of venous infarction
9. Cerebellum — avoid retraction injury

Equipment

• Operating microscope
• Facial nerve stimulator (monopolar and bipolar probes) — ESSENTIAL
• CUSA for tumor debulking
• High-speed drill (diamond burr for IAC drilling)
• Microsurgical instruments (micro scissors, dissectors, hooks)
• Bipolar (fine tip, low setting near facial nerve)
• Hemostatic agents
• Abdominal fat graft (for IAC packing and dead space)
• Bone wax
• Dural substitute

Monitoring

• Continuous facial EMG (CN VII) — CRITICAL; detects mechanical irritation
• Facial nerve stimulator — direct stimulation to locate nerve on tumor
• BAER — hearing preservation monitoring
• SSEPs
• Optional: CN V, CN IX/X/XI EMG (large tumors)

Anesthesia Considerations

• Arterial line
• Foley
• NO long-acting paralytic after intubation — facial EMG monitoring requires no paralysis
• Short-acting paralytic for intubation only, then allow to wear off
• Cefazolin 2g IV
• Dexamethasone 10 mg IV
• Mannitol 0.5-1 g/kg
• Antiemetics (ondansetron — posterior fossa high nausea risk)

Potential Complications & Contingencies

1. Facial nerve palsy — most feared; intraoperative stimulation guides preservation; if nerve anatomically intact, may still have temporary palsy (neuropraxia) → House-Brackmann grading post-op; eye care essential
2. Hearing loss — labyrinthine artery injury, cochlear nerve stretch; BAER monitoring; accept loss if necessary for facial nerve preservation
3. CSF leak — watertight closure, fat graft in IAC; if post-op leak → lumbar drain or wound revision
4. Meningitis — from CSF leak pathway; monitor for fever/meningismus
5. Cerebellar hematoma/edema — minimize retraction
6. Residual/recurrent tumor — planned subtotal resection if facial nerve at risk → radiosurgery for residual
7. Lower cranial nerve palsy — swallowing difficulty, voice hoarseness; speech/swallow eval

Operative Note Template

[Include: approach, tumor size, facial nerve location on tumor, stimulation thresholds throughout case, facial nerve anatomic preservation, extent of resection, IAC drilling, BAER monitoring results, fat graft placement, closure]

Postoperative Plan

• ICU x 24-48 hours (posterior fossa)
• Neuro checks q1h — posterior fossa precautions
• Facial nerve assessment: House-Brackmann grade hourly initially
  • If HB > III: Ophthalmology consult for eye care (corneal exposure)
  • Eye lubrication (artificial tears q1h, ointment at night)
  • Moisture chamber at night
  • Gold weight consideration if persistent palsy
• CT head 6 hours post-op
• Audiogram before discharge (if hearing preservation attempted)
• HOB 30 degrees
• Dexamethasone taper
• Anti-emetics PRN
• DVT prophylaxis
• CSF leak monitoring: Watch incision and nose (rhinorrhea if via IAC/mastoid)
• MRI with gadolinium at 3-6 months (extent of resection)
• If subtotal resection: Plan for surveillance MRI and possible Gamma Knife for residual
• Follow-up: 2-4 weeks clinic; serial MRI; audiometry annually
• NF2 patients: Genetics, screening for other tumors (meningiomas, spinal tumors)

Chief-Level Case Review

Use these as the senior-level mental model for Vestibular Schwannoma (Acoustic Neuroma) Resection:

• Decision point: Decide the real endpoint before opening: cure, cytoreduction, diagnosis, decompression, separation from critical structures, or safe maximal resection.
• Technical lever: Map what must be left behind: perforators, cranial nerves, venous sinuses, eloquent cortex/tracts, hypothalamus/pituitary axis, and adherent capsule planes.
• Bailout: Sequence matters: devascularize early when safe, create CSF/working space, debulk before traction, and preserve the arachnoid plane unless oncologic goals justify violating it.
• Postop watch: The postop plan should match the risk structure: endocrine/vision/swallow/CN checks, steroid taper, seizure plan, MRI timing, CSF-leak watch, and adjuvant-treatment handoff.

Common Pimp Questions

Use these to pressure-test preparation for Vestibular Schwannoma (Acoustic Neuroma) Resection:

1. What is the surgical goal: gross-total, maximal safe, decompression, diagnosis, or cytoreduction?
2. What eloquent cortex, tract, cranial nerve, vessel, or sinus defines the stopping point?
3. What adjunct changes the case: navigation, mapping, 5-ALA, ultrasound, endoscope, ICG, or neuromonitoring?
4. What is the edema, steroid, seizure, DVT, and postop imaging plan?
5. What complication would you check for first in PACU based on this lesion location?

Attending Preference Variables

Items that commonly vary by surgeon or institution:

• Extent-of-resection goal and functional stopping points: [attending-specific]
• Mapping/monitoring, 5-ALA, ultrasound, ICG, endoscope, or tractography preferences: [attending-specific]
• Steroid, antiepileptic, mannitol/hypertonic saline, and antibiotic plan: [attending-specific]
• Postop MRI timing, ICU/floor threshold, and adjuvant-referral workflow: [attending-specific]